Raymond James Financial Services Advisors’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-370
| Closed | -$11.5K | – | 3403 |
|
2022
Q4 | $11.5K | Hold |
370
| – | – | ﹤0.01% | 3164 |
|
2022
Q3 | $22K | Sell |
370
-5
| -1% | -$297 | ﹤0.01% | 3135 |
|
2022
Q2 | $29K | Buy |
+375
| New | +$29K | ﹤0.01% | 3112 |
|
2022
Q1 | – | Sell |
-485
| Closed | -$45K | – | 3431 |
|
2021
Q4 | $45K | Hold |
485
| – | – | ﹤0.01% | 3175 |
|
2021
Q3 | $98K | Buy |
485
+5
| +1% | +$1.01K | ﹤0.01% | 3110 |
|
2021
Q2 | $103K | Buy |
+480
| New | +$103K | ﹤0.01% | 3123 |
|